Alzamend Neuro share price logo

Alzamend Neuro

NASDAQ: ALZN

$1.84

+0.01

(+0.55%)

Live

as on

Alzamend Neuro Stock Performance

as on September 18, 2026 at 5:57 am IST

  • Day's Low

    $1.82
    $1.84
    downward going graph

    1.09%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.84
    $2.68
    downward going graph

    54.35%

    Downside

    45.65%

    Upside

    downward going graph

Alzamend Neuro share price movements today

Previous Close
$1.83
Open
$1.82
Volume
289.9K
Market Cap
$8.6M
Day's Low - High
$1.82 - $1.84
52 Week Low - High
$0.84 - $2.68

Alzamend Neuro Historical Returns

1 Month Return
+ 15.82 %
3 Month Return
+ 46.4 %
1 Year Return
-26.8 %
3 Year Return
-99.44 %
5 Year Return
-99.95 %

Alzamend Neuro Stock Fundamentals & Key Indicators

Check Alzamend Neuro market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.6M

EPS (TTM)

-2.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.77

Industry PE ratio

-4.09

PEG Ratio

-0.004552523316667967

EBITDA

-9.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-277.88%

Alzamend Neuro Stock Valuation

Track how Alzamend Neuro P/E has moved over time to understand its valuation trends.

Alzamend Neuro in the last 5 years

  • Overview

  • Trends

Lowest (-330.27x)

April 30, 2022

Industry (-4.09x)

April 30, 2026

Today (-0.43x)

April 30, 2026

Highest (-0.43x)

April 30, 2026

LowHigh

Today’s Price to Earnings Ratio: -0.43x

Alzamend Neuro vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alzamend Neuro with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$8.6M-99.95%-0.770.00%0.00%
BUY$43.9B527.35%NA0.00%0.00%
BUY$130.4B172.58%29.7186.04%0.00%
BUY$57.4B-66.14%-18.02-12.57%0.00%
BUY$81.7B18.83%18.4884.86%0.48%

Stock Returns calculator for Alzamend Neuro Stock including INR - Dollar returns

The Alzamend Neuro stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Alzamend Neuro investment value today

Current value as on today

₹80,339

Returns

-₹19,661

(-19.66%)

Returns from Alzamend Neuro Stock

-₹26,400 (-26.4%)

Dollar Impact

₹6,739 (+6.74%)

Analyst Recommendation on Alzamend Neuro Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Alzamend Neuro. Average target price of $26

Alzamend Neuro Share Price Target

Get share price movements and forecasts by analysts on Alzamend Neuro.

What analysts predicted

92.92%UPSIDE

Target Price

$26

Current Price

$1.84

Analyzed by

1 Analysts

Target

$26.00

Alzamend Neuro target price $26, a slight upside of 92.92% compared to current price of $1.84. According to 1 analysts rating.

Alzamend Neuro Quarterly Profit & Loss

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
0
Operating Income
0
0
-1
-1
-1
-2
0
-2
-2
-3
EBITDA
0
0
-1
-1
-1
-2
0
-2
-2
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
-1
-1
-1
-2
-1
-2
-2
-3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
0
-1
-1
-1
-2
-1
-2
-2
-3
Net Profit Margin
-16.67%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Alzamend Neuro Annual Profit & Loss

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-1
0
-5
-4
-4
-12
-14
-9
-4
-8
EBITDA
0
0
-5
-4
-4
-12
-14
-9
-4
-8
Interest Expense
-
-
-
-
0
0
0
0
0
0
Depreciation
1
0
-
-
-
0
0
0
0
0
Income Before Tax
-1
0
-4
-4
-5
-12
-14
-9
-4
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
0
-4
-4
-5
-12
-14
-9
-4
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Alzamend Neuro Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Net Income
0
0
-1
0
-1
-2
-1
-2
-2
-3
Operating Cash Flow
-1
-1
-3
-1
0
-2
-1
-1
-2
-1
Investing Cash Flow
-
0
-
-
0
-
-
-
-
-
Financing Cash Flow
1
1
6
0
1
4
-
-
0
8
Change in Cash
0
0
2
0
0
1
-1
-1
-2
6

Alzamend Neuro Annual Cash Flow

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Net Income
-1
0
-4
-4
-5
-12
-14
-9
-4
-8
Operating Cash Flow
-1
-2
-1
-2
-2
-6
-8
-8
-6
-8
Investing Cash Flow
-
0
0
0
0
0
-
0
0
-
Financing Cash Flow
1
2
0
2
4
18
0
3
10
4
Change in Cash
0
0
0
0
1
12
-8
-4
3
-3

Mutual Funds that own Alzamend Neuro Stock

Check out the Mutual Funds with significant holdings in Alzamend Neuro.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.550446%
26563
Victory Portfolios III
0.105207%
5077
VANGUARD INDEX FUNDS
0.091178%
4400

Global Institutional Holdings in Alzamend Neuro

Funds
Holdings
Vanguard
0.16%

Insights on Alzamend Neuro

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ALZN stock has moved up by 7.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 27.1% return, outperforming this stock by 126.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 482.5% return, outperforming this stock by 509.3%

About Alzamend Neuro

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
OrganisationAlzamend Neuro
Headquarters3480 Peachtree Road NE, Atlanta, GA, United States, 30326
IndustryBiotechnology
CEOMr. Stephan Jackman
E-voting on sharesClick here to vote

Key Management of Alzamend Neuro

Name

Title

Mr. Stephan Jackman

CEO & Director

Mr. Milton Charles Ault III

Founder & Vice Chairman

Mr. David J. Katzoff

Chief Financial Officer

Mr. Henry C. W. Nisser Esq.

Executive VP, General Counsel & Director

Mr. Kenneth S. Cragun CPA

Senior Vice President of Finance

FAQs

What is Alzamend Neuro share price today?

Alzamend Neuro share price today is $1.84 as on . Alzamend Neuro share today touched a day high of $1.84 and a low of $1.82.

What is the 52 week high and 52 week low for Alzamend Neuro share?

Alzamend Neuro share touched a 52 week high of $2.68 on and a 52 week low of $0.84 on . Alzamend Neuro stock price today i.e. is trending at $1.84,which is 31.34% down from its 52 week high and 119.05% up from its 52 week low.

What is Alzamend Neuro's market capitalisation today?

Alzamend Neuro market capitalisation is $0.00T as on .

How to invest in Alzamend Neuro Stock (ALZN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alzamend Neuro on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alzamend Neuro Shares that will get you 0.8152 shares as per Alzamend Neuro share price of $1.84 per share as on September 18, 2026 at 12:27 am IST.

What is the minimum amount required to buy Alzamend Neuro Stock (ALZN) from India?

Indian investors can start investing in Alzamend Neuro (ALZN) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in Alzamend Neuro stock (as per the Rupee-Dollar exchange rate as on ). Based on Alzamend Neuro share’s latest price of $1.84 as on September 18, 2026 at 12:27 am IST, you will get 5.4348 shares of Alzamend Neuro. Learn more about fractional shares .

What are the returns that Alzamend Neuro has given to Indian investors in the last 5 years?

Alzamend Neuro stock has given -99.95% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?